engaging clinicians and patients in the concept and importance … · 2017-05-03 · transforming...

23
Engaging Clinicians and Patients in the Concept and Importance of Activation Valuing Individuals -Transforming Participation in Chronic Kidney Disease Jonathon Hope

Upload: others

Post on 26-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Engaging Clinicians and Patients in the Concept and Importance of

ActivationValuing Individuals -Transforming Participation

in Chronic Kidney Disease

Jonathon Hope

Page 2: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal
Page 3: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

The Passive Patient

| 3

Healthcare can be profoundly disempowering

This can be even more challenging when the condition is highly medicalised (e.g. ESRD)

But most patients want to be treated as active participants – as co-producers of health

Transforming Participation in Chronic Kidney Disease Rachel Gair

Page 4: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

To a person centred approach…

| 4Transforming Participation in Chronic Kidney Disease Rachel Gair

Page 5: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Day to day decision making: self management

| 5Transforming Participation in Chronic Kidney Disease Rachel Gair

Hours with NHS / social care professional = 5-10 in a year

Self management= 8,750-55 in a year

Page 6: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

The Challenge… takes a long time to develop skills

| 6Transforming Participation in Chronic Kidney Disease Rachel Gair

Page 7: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

So…

| 7Transforming Participation in Chronic Kidney Disease Rachel Gair

The system should work in partnership with people with LTCs in order to support them to develop the knowledge, skills and confidence to manage their own wellbeing, health and healthcare

Page 8: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Co-producing health

| 8Transforming Participation in Chronic Kidney Disease Rachel Gair

Page 9: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

What are the questions the TP – CKD programme is asking?

| 9

Can we routinely collect measures relating to patient/teams activation, QOL outcomes and patient experience within 10 renal units?

Can we introduce interventions that will increase a patient’s and team’s activation?

Does an activated patient have better outcomes?

Transforming Participation in Chronic Kidney Disease Rachel Gair

Page 10: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Overall Aspiration

| 10

How do we change conversations and behaviours? We believe that targeting solely patients unlikely to

achieve necessary cultural change What are the characteristics within teams that support

and drive person centred care? How can this be shared with other LTC? Sustainability – no additional resource Co-production as a core value

Transforming Participation in Chronic Kidney Disease Rachel Gair

Page 11: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Organisational chart supporting co-production

| 11Transforming Participation in Chronic Kidney Disease Rachel Gair

NHS England (co-production champion) – UKRR

Programme ‘Core’ group (patient and clinical leaders)

Programme board – co chaired expert patient (co-production champion) and clinician with 12/22 board members patients

Workstreams – all 3 co-chaired by patient/clinical partnership and patient/clinical workstream members

Rachel Gair (co-production champion)

Renal Unit working groups with clinical and patient members (the start of real cultural change)

No co-production without representative governance!

Page 12: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Terminology

| 12Transforming Participation in Chronic Kidney Disease Rachel Gair

EQ-5D-5LIPOS renal

Self developed

Patient Activation Measure (PAM)Clinician-support for PAM (CS-PAM)

• PAM– Patient Activation Measure– Skills, knowledge and confidence to manageyour long term condition

• PROMs– Patient Reported Outcome Measure– Quality of life

• Generic• Disease specific

• PREM– Patient Reported Experience Measure– Questions relating to their healthcare experience– All Renal Units X 1 per year

Page 13: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Engagement – HOW

| 13

• 3 Learning Events – teams had to comprise 50% patients

• Teams developed a 30-60-90 day implementation plan

• Encouraged PDSA/AAL with each small cycle of spread

• PCCF – visits, calls, share learning, cohort calls, newsletters, bulletins

• Shared challenges and successes – peer assist

• Feedback of survey results to clinical teams and patients via PV

• Development of an Intervention Toolkit

Transforming Participation in Chronic Kidney Disease Rachel Gair

Page 14: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Your Health Survey Returns

| 14Transforming Participation in Chronic Kidney Disease Rachel Gair

Cohort 1 UnitsTOTAL NUMBER OF RETURNS

Birmingham Heartlands Hospital (Heart of England NHS Foundation Trust) 111

St Luke’s Hospital (Bradford Teaching Hospitals NHS Foundation Trust) 180Coventry (University Hospitals Coventry & Warwickshire NHS Trust) 123Derby (Derby Teaching Hospitals NHS Foundation Trust) 112Hammersmith Hospital (Imperial College Hospital NHS Trust) 61King’s London (King’s College Hospital NHS Trust) 368

Freeman Hospital (Newcastle Upon Tyne Hospitals NHS Foundation Trust) 511

City Hospital ( Nottingham University Hospitals NHS Trust) 465Derriford Hospital ( Plymouth Hospitals NHS Trust) 42

Northern General Hospital (Sheffield Teaching Hospitals NHS Foundation Trust) 326

Total Returns 2,299

Cohort 2 Units TOTAL NUMBER OF RETURNS

Royal Sussex County Hospital (Brighton and Sussex University Hospital Trust) 116New Cross Hospital (Royal Wolverhampton NHS Trust) 61

Royal Stoke University Hospital (University Hospitals of North Midlands NHS Trust) 43Leeds (The Leeds Teaching Hospital NHS Trust) 0Total Returns 159

Page 15: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Phase 1 – CS-PAM Results

| 15Transforming Participation in Chronic Kidney Disease Rachel Gair

CS-PAM - Clinicians’ beliefs and attitudes toward patient self-management

Page 16: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

PAM: Patient Activation Measure

| 16Transforming Participation in Chronic Kidney Disease Rachel Gair

Patient activation is a measure of how engaged people are in managing their own health

Page 17: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

PROM – Patient Reported Outcome Measure

| 17Transforming Participation in Chronic Kidney Disease Rachel Gair

0%10%20%30%40%50%60%70%80%90%

100%

Not at all/slightly

At leastmoderately

Page 18: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Intervention Toolkit

| 18Transforming Participation in Chronic Kidney Disease Rachel Gair

Page 19: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Lessons Learned – Emerging Patterns

| 19

Empower patients from the beginning – governance

‘Be the change you want to see’ - mirror co-production culture change in programme team and board

Share power - Senior clinical champion + patient champion

Leadership – moving towards changing practice

Start small and build – QI cycles of change

Engagement of whole patient/clinical team to really embed

Different ways of working – volunteers – IT – process

The power of patient involvement (e.g. measurement)

Transforming Participation in Chronic Kidney Disease Rachel Gair

Page 20: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Phase 2 – Spread and Sustainability

Transforming Participation in Chronic Kidney Disease Date | 20

Continue spread across 14 units Continue re-surveying of patients – embedding Provision of workshops to units – discussing data + changing

practice Introduction of interventions: Ask 4 Questions Communication – using PAM in conversations Patient View Care planning – goal setting Peer support

Page 21: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Key messages so far

Transforming Participation in Chronic Kidney Disease Date | 21

‘Be the change you want to see’ - mirror co-production/ culture shift you want to see in programme team and board

Peer assist model supports cultural shift – vs. last year Developing a faculty system – group of experts Transferability to other LTC – far reaching change Influence commissioning approach – testing interventions No additional resource to units – supports sustainable change Patient stories – website PAM/CSPAM combination - powerful

Page 22: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal
Page 23: Engaging Clinicians and Patients in the Concept and Importance … · 2017-05-03 · Transforming Participation in Chronic Kidney Disease . Rachel Gair | 12. EQ-5D-5L. IPOS renal

Richard FluckClinical Co-Chair Internal Medicine Programme of Care NHS [email protected]

Ron CullenDirectorUK Renal [email protected]

How to find out more

Karen ThomasThink Kidneys Programme ManagerUK Renal [email protected]

Rachel GairPerson Centred Care FacilitatorUK Renal [email protected]

Catherine StannardProgramme Support OfficerUK Renal [email protected]

Contact Think Kidneys

www.linkedin.com/company/think-kidneyswww.twitter.com/ThinkKidneyswww.facebook.com/thinkkidneyswww.youtube.com/user/thinkkidneyswww.slideshare.net/ThinkKidneyswww.thinkkidneys.nhs.uk

| 23Transforming Participation in Chronic Kidney Disease Rachel Gair